|
|
|
|
| LEADER |
00000cam a2200000Mi 4500 |
| 001 |
ocn984688420 |
| 003 |
OCoLC |
| 005 |
20240623213015.0 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
170419s2017 gw ob 001 0 eng d |
| 010 |
|
|
|a 2016044057
|
| 040 |
|
|
|a DEGRU
|b eng
|e rda
|e pn
|c DEGRU
|d GWDNB
|d OCLCQ
|d OCLCO
|d DEGRU
|d QHU
|d IDEBK
|d EBLCP
|d YDX
|d MERUC
|d IUL
|d ORU
|d OCLCF
|d TEFOD
|d VGM
|d OTZ
|d NRC
|d CUY
|d U3G
|d VLB
|d OCLCO
|d OCLCA
|d UIU
|d OCLCO
|d COCUF
|d OCLCQ
|d LOA
|d OCLCO
|d K6U
|d ICG
|d OCLCO
|d STF
|d OCLCO
|d ZCU
|d OCLCO
|d UAB
|d OCLCO
|d VT2
|d U3W
|d AU@
|d WYU
|d OCLCO
|d OCLCQ
|d OCLCO
|d LVT
|d OCLCA
|d TKN
|d OCLCO
|d OCLCA
|d DKC
|d OCLCO
|d UKAHL
|d UX1
|d OCLCQ
|d OCLCO
|d OCLCQ
|d UUM
|d OCLCA
|d OCLCQ
|d AUD
|d SDF
|d OCLCO
|d S2H
|d OCLCO
|d N$T
|d OCLCQ
|d OCLCO
|d OCLCL
|d UEJ
|
| 016 |
7 |
|
|a 1129320057
|2 DE-101
|
| 016 |
7 |
|
|a 101693052
|2 DNLM
|
| 019 |
|
|
|a 962230469
|a 982010838
|a 992511788
|a 992573312
|a 1055400021
|a 1066610132
|a 1081282225
|a 1164786320
|a 1228545592
|
| 020 |
|
|
|a 9783110493764
|
| 020 |
|
|
|a 3110493764
|
| 020 |
|
|
|a 3110493551
|
| 020 |
|
|
|a 9783110496284
|
| 020 |
|
|
|a 3110496283
|
| 020 |
|
|
|a 9783110493559
|q (electronic bk.)
|
| 024 |
7 |
|
|a 10.1515/9783110493764
|2 doi
|
| 024 |
3 |
|
|a 9783110493559
|
| 024 |
7 |
|
|a urn:nbn:de:101:1-2017040527596
|2 urn
|
| 035 |
|
|
|a (OCoLC)984688420
|z (OCoLC)962230469
|z (OCoLC)982010838
|z (OCoLC)992511788
|z (OCoLC)992573312
|z (OCoLC)1055400021
|z (OCoLC)1066610132
|z (OCoLC)1081282225
|z (OCoLC)1164786320
|z (OCoLC)1228545592
|
| 037 |
|
|
|a 5F41FC1F-3E7B-49CF-9561-5309AA8121DB
|b OverDrive, Inc.
|n http://www.overdrive.com
|
| 050 |
|
4 |
|a QH588.S83
|
| 072 |
|
7 |
|a MED072000
|2 bisacsh
|
| 072 |
|
7 |
|a SCI010000
|2 bisacsh
|
| 072 |
|
7 |
|a SCI017000
|2 bisacsh
|
| 072 |
|
7 |
|a SCI029000
|2 bisacsh
|
| 072 |
|
7 |
|a SCI049000
|2 bisacsh
|
| 049 |
|
|
|a HCDD
|
| 130 |
0 |
|
|a Stem cells (Haider)
|
| 245 |
1 |
0 |
|a Stem cells :
|b from drug to drug discovery /
|c Khawaja Husnain Haider (Ed.).
|
| 264 |
|
1 |
|a Berlin ;
|a Boston :
|b Walter de Gruyter,
|c [2017]
|
| 264 |
|
4 |
|c ©2017
|
| 300 |
|
|
|a 1 online resource (232 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a text file
|b PDF
|2 rda
|
| 505 |
0 |
0 |
|t Frontmatter --
|t Preface --
|t Contents --
|t Contributing authors --
|t List of abbreviations --
|t 1. Human pluripotent stem-cell-derived vascular cells: in vitro model for angiogenesis and drug discovery --
|t 2. Role of small molecules in the cardiac differentiation of mesenchymal stem cells --
|t 3. MicroRNAs as modulators of endothelial differentiation of stem cells: role in vascular regenerative medicine --
|t 4. Cells for the repair of damaged skin and cartilage --
|t 5. The skeletal muscle stem cells: biology and use in regenerative medicine --
|t 6. Nanoparticle-based genetic engineering of mesenchymal stem cells --
|t 7. Neural stem cells in regenerative medicine --
|t 8. "Paracrining" the heart with stem cells --
|t Index.
|
| 520 |
|
|
|a Stem cell based therapy is a 21st century approach of therapeutic intervention which epitomizes a shift from conventional symptomatic treatment strategy to addressing the root cause of the disease process. This is especially a hope for the patients suffering from diseases such as Alzheimer, diabetes, myocardial infarction and other diseases which have always been considered as incurable. Moreover, stem cells provide excellent in vitro disease models for drug development. This book is a compilation of the bench experience of experts from various research labs involved in the cutting edge area of research, describing the use of stem cells both as part of the combinatorial therapeutic intervention approach and as tools (disease model) during drug development.
|
| 546 |
|
|
|a In English.
|
| 588 |
0 |
|
|a Online resource; title from PDF title page (publisher's Web site, viewed Apr. 18, 2017).
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 650 |
|
0 |
|a Stem cells.
|
| 650 |
|
7 |
|a SCIENCE / Biotechnology.
|2 bisacsh
|
| 650 |
|
7 |
|a Stem cells
|2 fast
|
| 650 |
|
7 |
|a Therapie
|2 gnd
|
| 650 |
|
7 |
|a Stammzelle
|2 gnd
|
| 650 |
|
7 |
|a Arzneimittelforschung
|2 gnd
|
| 700 |
1 |
|
|a Haider, Khawaja Husnain.
|
| 758 |
|
|
|i has work:
|a Stem Cells - From Drug to Drug Discovery (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCYmMKYk34v67vbJxVBXY4C
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|z 9783110496284
|
| 856 |
4 |
0 |
|u https://ebookcentral.proquest.com/lib/holycrosscollege-ebooks/detail.action?docID=4830573
|y Click for online access
|
| 903 |
|
|
|a EBC-AC
|
| 994 |
|
|
|a 92
|b HCD
|